A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...

Many of us instinctively understand the positive effects of nature on our health and well-being, yet our lives are often too ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

His family’s history with the disease has inspired his most recent activism.

Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...

Regulatory upheaval in the US and a venture capital drought are dampening investor appetites, but there are still diamonds in ...

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Researchers report that eight healthy babies were born with the help of an experimental technique that uses DNA from three ...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best oversold NASDAQ stocks to buy now. In a report released on ...

The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains ...

Kezar Life Sciences said a partial clinical hold on a trial for its zetomipzomib program to treat autoimmune hepatitis has been lifted by the Food and Drug Administration. The FDA lifted the hold ...